Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Glenmark Pharmaceuticals Limited Press Release Jan 10 2023

· Issued by Glenmark Pharmaceuticals Limited via NSE India

Filed with NSE · · 3 pages · English

On 6ix: 6ix.com/news/glenmark-pharmaceuticals-limited-press-release-jan-10-2023

Watch Glenmark Pharmaceuticals' latest callGlenmark Pharmaceuticals (NSE:GLENMARK) Q2 2026 Earnings Call · Replay · Nov 6

Release

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 10, 2023, titled "Glenmark Pharmaceuticals launches Bumetanide Injection USP, 1 mg/4 mL (0.25mg/mL) Single-Dose Vials and 2.5 mg/10 mL (0.25 mg/mL) Multi-Dose Vials".

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases